Our Discovery
AMUN-003
AmunBio’s patented AMUN-003 will selectively replicate in the tumor cells, block suppression of the immune response inside the tumor, stimulate the recruitment of cancer killing immune cells, target metastasis and avoid non-specific inflammation. Direct injection of AMUN-003 will thus inhibit tumor growth and metastases, and enhance immunotherapy. AMUN-003 can potentially be administered locally or systemically offering the treatment of multiple cancer.
